Stocks

The table gives an overview of all stocks, alphabetically sorted.
 WntResearch WNT Apr 3, 2020 1.75 -5.65   
 Wonderful Times Group WTG Apr 3, 2020 8.40 0.00   
 Xact Bear XACTBEAR Apr 3, 2020 57.37 +1.99   
 Xact Bear 2 XACTBEAR2 Apr 3, 2020 45.70 +2.93   
 Xact Bull XACTBULL Apr 3, 2020 315.15 -2.17   
 Xact Bull 2 XACTBULL2 Apr 3, 2020 548.50 -2.89   
 XACT Högutdelande XACTHDIV Apr 3, 2020 106.28 -0.49   
 Xact OMXS30 XACTOMXS30 Apr 3, 2020 176.12 -1.46   
 XANO Industri B XANOB Apr 3, 2020 79.60 -0.50   
 Xavitech B XAVIB Apr 3, 2020 1.19 -0.83   
 Xbrane Biopharma XBRANE Apr 3, 2020 30.90 -1.59   
 Xintela XINT Apr 3, 2020 3.52 -1.68   
 XMReality XMR Apr 3, 2020 2.32 +4.04   
 Xspray Pharma XSPRAY Apr 3, 2020 53.60 +2.68   
 Xvivo Perfusion XVIVO Apr 3, 2020 100.00 -4.58   
 XXL XXLO Apr 3, 2020 7.90 -3.66   
 Yara International YARO Apr 3, 2020 340.00 0.00   
 Zaplox ZAPLOX Apr 3, 2020 0.69 +5.38   
 Zenergy B ZENZIPB Apr 3, 2020 0.33 +0.61   
 Zenicor ZENI Apr 3, 2020 9.00 -5.26   
 ZetaDisplay ZETA Apr 3, 2020 14.20 -0.35   
 Ziccum ZICC Apr 3, 2020 13.15 +0.38   
 ZignSec ZIGN Apr 3, 2020 7.31 +2.24   
 Zinzino B ZZB Apr 3, 2020 21.40 +0.47   
 Zoomability ZOOM Apr 3, 2020 3.56 -2.73   
 Zordix B ZORDIXB Apr 3, 2020 7.02 +0.29   
 Zutec ZUTEC Apr 3, 2020 1.30 -1.52   
 Zwipe ZWIPE Apr 3, 2020 3.66 0.00   
 ÅF Pöyry B AFB Apr 3, 2020 145.50 -0.34   
 Öresund ORES Apr 3, 2020 97.00 -1.02   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK